Aramchol + Placebo

Phase 2Terminated

0 views this week 0 watching💤 Quiet

Interest: 17/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Gallstones

Conditions

Gallstones

Trial Timeline

Oct 1, 2014 → Oct 1, 2015

NCT ID

NCT02325492

About Aramchol + Placebo

Aramchol + Placebo is a phase 2 stage product being developed by Galmed Pharmaceuticals for Gallstones. The current trial status is terminated. This product is registered under clinical trial identifier NCT02325492. Target conditions include Gallstones.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (3)

NCT ID	Phase	Status	Start	Completion	Indication
NCT02803996	Phase 1	Completed	May 1, 2016	Dec 1, 2016	Healthy Volunteers
NCT02325492	Phase 2	Terminated	Oct 1, 2014	Oct 1, 2015	Gallstones
NCT02374437	Phase 1	Completed	Apr 1, 2014	Dec 1, 2014	Healthy Volunteers